Business
Mixed Earnings Fail to Boost Stock Market as Uncertainty Persists
Companies have been reporting robust earnings in the third quarter, surpassing both top and bottom-line expectations. However, these impressive strong earnings have failed to uplift...
SLB Reports Sequential Dip in North American Sales, Expects Growth in International Markets
Schlumberger (SLB), the world’s largest oil-services provider, has recorded its first sequential decline in North American sales since the onset of 2021. This shift comes...
XORTX Therapeutics Inc Witnesses Surge in Stock Price
The stock price of clinical-stage biopharmaceutical firm XORTX Therapeutics Inc (NASDAQ: XRTX) has experienced a notable upswing, despite the absence of substantial news releases. According...
Lipella Pharmaceuticals Sees Surge in Shares Following FDA Approval for Clinical Trial
Shares of Lipella Pharmaceuticals, a clinical-stage biotechnology company (Nasdaq: LIPO), experienced a notable surge on Friday amid robust trading activity, with over 38 million shares...
Hub Cyber Security Shares Surge as Company Bolsters Israel’s Digital Defenses
Shares of Hub Cyber Security (HUBC) surged on Friday following the company’s pivotal announcement of its participation in Israel’s digital ‘Fortress’ defenses. This development comes...
Eli Lilly Expands Mounjaro Clinical Trial to Include Children with Obesity
Pharmaceutical giant Eli Lilly is set to broaden the scope of its clinical trial for the diabetes drug Mounjaro, which will now encompass patients as...
Vietnamese EV Maker VinFast Forms $1B Share Subscription Deal with Yorkville Advisors
Vietnamese electric vehicle manufacturer VinFast announced on Friday a strategic share subscription agreement of up to $1 billion with U.S.-based investment firm Yorkville Advisors. Under...
Webuy Global Ltd Prices IPO, Shares Decline
Webuy Global, a prominent Southeast Asian community e-commerce retailer trading on the Nasdaq exchange under the ticker symbol WBUY, has disclosed the pricing details of...
Renovaro Biosciences Shares Take a Dip After Surging to 52-Week High
In a strategic move, Century City-based gene and immunotherapy firm, Renovaro Biosciences, rebranded itself as Renovaro in early August, signaling a fresh start encapsulated in...
Arcutis Biotherapeutics Shares Plunge Over 22% After $100 Million Equity Offering Announcement”
Shares of early commercial-stage medical dermatology company Arcutis Biotherapeutics Inc witnessed a significant drop of over 22% on Friday following the announcement of its intention...